Evaluation of two rapid antigen tests to detect SARS-CoV-2 in a hospital setting.
Evaluation of two rapid antigen tests to detect SARS-CoV-2 in a hospital setting.
复制标题
两种快速抗原检测方法在医院检测SARS-CoV-2的评价
DOI:
10.1007/s00430-020-00698-8
复制
发表时间:
2021-03
影响因子:
5.4
通讯作者:
Keppler OT
中科院分区:
文献类型:
--
作者:
Osterman A;Baldauf HM;Eletreby M;Wettengel JM;Afridi SQ;Fuchs T;Holzmann E;Maier A;Döring J;Grzimek-Koschewa N;Muenchhoff M;Protzer U;Kaderali L;Keppler OT
Successful containment strategies for the SARS-CoV-2 pandemic will depend on reliable diagnostic assays. Point-of-care antigen tests (POCT) may provide an alternative to time-consuming PCR tests to rapidly screen for acute infections on site. Here, we evaluated two SARS-CoV-2 antigen tests: the STANDARD™ F COVID-19 Ag FIA (FIA) and the SARS-CoV-2 Rapid Antigen Test (RAT). For diagnostic assessment, we used a large set of PCR-positive and PCR-negative respiratory swabs from asymptomatic and symptomatic patients and health care workers in the setting of two University Hospitals in Munich, Germany, i.e. emergency rooms, patient care units or employee test centers. For FIA, overall clinical sensitivity and specificity were 45.4% (n = 381) and 97.8% (n = 360), respectively, and for RAT, 50.3% (n = 445) and 97.7% (n = 386), respectively. For primary diagnosis of asymptomatic and symptomatic individuals, diagnostic sensitivities were 60.9% (FIA) (n = 189) and 64.5% (RAT) (n = 256). This questions these tests’ utility for the reliable detection of acute SARS-CoV-2-infected individuals, in particular in high-risk settings. We support the proposal that convincing high-quality outcome data on the impact of false-negative and false-positive antigen test results need to be obtained in a POCT setting. Moreover, the efficacy of alternative testing strategies to complement PCR assays must be evaluated by independent laboratories, prior to widespread implementation in national and international test strategies.
登录
查看更多内容
影响因子:
19
作者:
Singanayagam, Anika;Patel, Monika;Gopal, Robin
通讯作者:
Gopal, Robin
影响因子:
9.4
作者:
Young S;Taylor SN;Cammarata CL;Varnado KG;Roger-Dalbert C;Montano A;Griego-Fullbright C;Burgard C;Fernandez C;Eckert K;Andrews JC;Ren H;Allen J;Ackerman R;Cooper CK
通讯作者:
Cooper CK
DOI:
10.1016/j.cmi.2020.09.057
发表时间:
2021-03
期刊:
Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases
影响因子:
--
作者:
Diao B;Wen K;Zhang J;Chen J;Han C;Chen Y;Wang S;Deng G;Zhou H;Wu Y
通讯作者:
Wu Y
DOI:
10.1016/j.jcv.2020.104412
发表时间:
2020-07-01
期刊:
Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology
影响因子:
--
作者:
van Kasteren, Puck B;van der Veer, Bas;Meijer, Adam
通讯作者:
Meijer, Adam
影响因子:
19
作者:
Konrad, Regina;Eberle, Ute;Sing, Andreas
通讯作者:
Sing, Andreas